Enliven Therapeutics
ELVN
ELVN
17 hedge funds and large institutions have $174M invested in Enliven Therapeutics in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+17
Holders Change %
–
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$64.4M |
| 2 |
O
OrbiMed
New York
|
+$43.6M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$23.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.2M |
| 5 |
DM
Deerfield Management
New York
|
+$8.02M |
Top Sellers
No sellers this quarter
